Products

By Eric Green, CEO of Trace Neuroscience, as part of the From The Trenches feature of LifeSciVC Few neurodegenerative diseases have clearer genetic causation than Huntington’s …

By Julia Pian, Senior Associate at Atlas Venture, as part of the From The Trenches features of LifeSciVC As Jonathan Larson beautifully explores in “Seasons of …

By, Arthur Tzianabos, CEO of Lifordi, as part of the From The Trenches feature of LifeSciVC I often hear biotech leaders refer to their company’s technology …

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC. I’m not a resolutions person but I’ve always loved …

By Abbas Kazimi, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC In early 2009, when global markets were bottoming out, …

By Cody Tranbarger, Entrepreneur In Residence at Atlas Venture, as part of the From The Trenches feature of LifeSciVC   What if the biggest obstacle to …

“When the going gets tough, the tough get going” By Ram Aiyar, CEO of Korro Bio, as part of the From the Trenches feature of LifeSciVC. …

By Jason Campagna, CMO of Q32 Bio, as part of the From The Trenches feature of LifeSciVC We’re entering a phase shift in biotech—one that extends …

The equity markets have collapsed in 2025, the IPO window is closed, the FDA is in turmoil, the NIH is being gutted… and it’s a great …

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC Drug discovery and development is a long, and often …